Onyx Biotec Statistics

Total Valuation

Onyx Biotec has a market cap or net worth of INR 941.05 million. The enterprise value is 1.23 billion.

Market Cap	941.05M
Enterprise Value	1.23B

Important Dates

The next estimated earnings date is Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Onyx Biotec has 18.13 million shares outstanding. The number of shares has increased by 8.08% in one year.

Current Share Class	18.13M
Shares Outstanding	18.13M
Shares Change (YoY)	+8.08%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	65.90%
Owned by Institutions (%)	n/a
Float	5.91M

Valuation Ratios

The trailing PE ratio is 14.94.

PE Ratio	14.94
Forward PE	n/a
PS Ratio	1.54
PB Ratio	3.33
P/TBV Ratio	3.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	27.79
EV / Sales	2.01
EV / EBITDA	10.64
EV / EBIT	14.45
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.21, with a Debt / Equity ratio of 1.07.

Current Ratio	1.21
Quick Ratio	0.69
Debt / Equity	1.07
Debt / EBITDA	2.62
Debt / FCF	n/a
Interest Coverage	3.22

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	17.31%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Onyx Biotec has paid 15.41 million in taxes.

Income Tax	15.41M
Effective Tax Rate	25.86%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	52.44
200-Day Moving Average	n/a
Relative Strength Index (RSI)	52.07
Average Volume (20 Days)	13,000

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Onyx Biotec had revenue of INR 609.58 million and earned 44.17 million in profits. Earnings per share was 3.47.

Revenue	609.58M
Gross Profit	219.90M
Operating Income	84.96M
Pretax Income	59.58M
Net Income	44.17M
EBITDA	115.33M
EBIT	84.96M
Earnings Per Share (EPS)	3.47

Full Income Statement

Balance Sheet

The company has 15.18 million in cash and 301.65 million in debt, giving a net cash position of -286.46 million or -15.80 per share.

Cash & Cash Equivalents	15.18M
Total Debt	301.65M
Net Cash	-286.46M
Net Cash Per Share	-15.80
Equity (Book Value)	282.74M
Book Value Per Share	21.21
Working Capital	60.36M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 36.07%, with operating and profit margins of 13.94% and 7.25%.

Gross Margin	36.07%
Operating Margin	13.94%
Pretax Margin	9.77%
Profit Margin	7.25%
EBITDA Margin	18.92%
EBIT Margin	13.94%
FCF Margin	n/a

Dividends & Yields

Onyx Biotec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.08%
Shareholder Yield	n/a
Earnings Yield	4.69%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1